Immune status and the efficacy of adjuvant radiotherapy for patients with localized Merkel cell carcinoma of the head and neck.

Mehran Behruj YusufJ GaskinsM E MayS MandishW WallW FisherP TennantJ JorgensenJ BumpousN Dunlap

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)

In this NCDB analysis, adjuvant RT was associated with decreased hazard of death for patients with localized MCC of the head and neck regardless of immune status and should be considered for both IS and IC patients.

Keyphrases

early stage
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
radiation therapy
locally advanced
patient reported outcomes